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Th  e contribution by Vermeulen and associates docu-
ments measurements of blood lactate in an impressively 
large number of patients with ST elevation myocardial 
infarction [1]. On admission to the cardiac catheteri-
zation laboratory, increases in arterial blood lactate in 
patients corresponded to the magnitude of the infarct. 
Some of the patients had clinical signs of circulatory 
shock, including increases in heart rate and decreases in 
arterial pressure. If there was less successful restoration 
of coronary blood ﬂ   ow after catheter interventions, 
disproportionately higher blood lactate concentrations 
were observed.
Increases in arterial blood lactate in coronary settings 
were therefore most probably accompanied by decreases 
in cardiac output and thus by decreases in systemic blood 
ﬂ  ows consistent with cardiogenic shock of corresponding 
severities. To the extent that lactate measurements were 
obtained early after admission, they were indeed likely to 
be predictive of both short-term and long-term out-
comes. In accor  dance with the historically useful Killip 
classiﬁ  cation, the close relationship among the outcomes 
in patients under  going primary percutaneous coronary 
interventions was conﬁ  rmed by DeGeare and colleagues 
[2]. Speciﬁ   cally, patients without physical signs 
characteristic of reduced systemic blood ﬂ   ows due to 
heart failure after acute myocardial infarction had a 
favorable outcome, and patients with reduction in cardiac 
output and heart failure had a poor prognosis.
Increases in lactate in settings of cardiogenic shock 
were ﬁ  rst reported by our group in 1974 [3] and secured 
the earlier ﬁ   ndings [4,5] that lactate measurement is 
highly predictive for outcomes of circulatory shock 
states. In the present report, myocardial infarction led to 
reduced cardiac work capacity and therefore reduced 
systemic blood ﬂ  ows. Th   e increases in lactate were then 
best explained by critical reduction in cardiac output, 
which is typically accompanied by physical signs, includ-
ing tachycardia hypotension, cyanosis and pallor, third 
heart sounds and cold extremities. Th  e sources of the 
lactate increase may in part be due to ischemic myo-
cardium, but the likelihood is that lactic excesses were 
primarily due to systemic circulatory failure. Unrelated 
causes of increased lactate are associated with struggling, 
convulsive seizures and hyperthermia, and must be 
excluded [6].
Th  e evolution of lactate measurement followed the 
early studies of Huckabee [7,8] who, largely on the basis 
of earlier investigations in exercise physiology and based 
on measurements of both serum pyruvate and lactate 
values, clariﬁ  ed the value of the so-called excess lactate as 
a quantitator corresponding to the systemic oxygen deﬁ  -
cit [4]. Subsequent workers conﬁ  rmed that excess lactate 
was a valuable measurement and yet later demonstrated 
that the measurement of lactate alone in blood or serum 
was suﬃ   cient [5,8-10]. With present methods of facile 
point-of-care laboratory measurements, as utilized in the 
study by Vermeulen and colleagues [1], lactate proved a 
useful prognosticator for the severity of myocardial 
infarction. When acute myocardial infarction was 
accompanied by lactic acidosis, systemic blood ﬂ  ow was 
critically reduced.
Th  e present report, therefore, again demonstrates the 
early prognostic value of lactate as an indicator for the 
severity of decreased systemic blood ﬂ  ows with corres-
pondingly poor outcomes and, in this instance, in 
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Increases in blood lactate refl  ect decreases in systemic 
blood fl  ows associated with low blood fl  ow states 
characteristic of circulatory shock. Accordingly, the 
report by Vermeulen and colleagues documents the 
use of the blood lactate measurement as a prognostic 
indicator in settings of ST elevation myocardial 
infarction. That lactate value therefore identifi  ed high-
risk patients as a complication, often with clinical signs 
of cardiogenic shock of corresponding severities.
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